Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men
In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2000-11, Vol.85 (11), p.4074-4080 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4080 |
---|---|
container_issue | 11 |
container_start_page | 4074 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 85 |
creator | BROWN, Gregory A VUKOVICH, Matthew D MARTINI, Emily R KOHUT, Marian L FRANKE, Warren D JACKSON, David A KING, Douglas S |
description | In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placebo (n = 27) for 28 days. Serum ASD, dihydrotestosterone (DHT), free and total testosterone, estradiol, prostate-specific antigen (PSA), and lipid concentrations were measured at week 0 and each week throughout the supplementation period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free testosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1-4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r2 = 0.024), free testosterone (r2 = 0.00), or estradiol (r2 = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r2 = 0.244; P < 0.05). Serum concentrations of high-density lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD, three times per day, does not increase serum total testosterone or PSA concentrations but does elicit increases in ASD, free testosterone, estradiol, and DHT and decreases serum high-density lipoprotein cholesterol concentrations. |
doi_str_mv | 10.1210/jc.85.11.4074 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70785726</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70785726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-ec3239f716dbc3706f5171b2868a882929e01177c87b180d27387efd776dc6e53</originalsourceid><addsrcrecordid>eNpF0DtLBDEUBeAgiq6P0lYGBLusuclkbqYU8QWCjYJdyCZ3cNbZZE1mC_-9s7hodZqPA-cwdg5iDhLE9dLPjZ4DzGuB9R6bQVtrjtDiPpsJIYG3KN-P2HEpSyGgrrU6ZEcAotW10jP2chdD8rmPVGUq6xQLlWpMlf_IKfa-cjHkVEaKFPo0oT6O7nMblRJ8C3XDv8llnoZQrSiesoPODYXOdnnC3u7vXm8f-fPLw9PtzTP3CnDk5JVUbYfQhIVXKJpOA8JCmsY4Y2QrWxIAiN7gAowIEpVB6gJiE3xDWp2wq9_edU5fGyqjXfXF0zC4SGlTLAo0GmUzQf4L_bSjZOrsOvcrl78tCLt90C69NdoC2O2Dk7_YFW8WKwr_enfZBC53wBXvhi676Pvy57AFNEb9AKrxdqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70785726</pqid></control><display><type>article</type><title>Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men</title><source>MEDLINE</source><source>Oxford University Press Journals</source><source>EZB Electronic Journals Library</source><creator>BROWN, Gregory A ; VUKOVICH, Matthew D ; MARTINI, Emily R ; KOHUT, Marian L ; FRANKE, Warren D ; JACKSON, David A ; KING, Douglas S</creator><creatorcontrib>BROWN, Gregory A ; VUKOVICH, Matthew D ; MARTINI, Emily R ; KOHUT, Marian L ; FRANKE, Warren D ; JACKSON, David A ; KING, Douglas S</creatorcontrib><description>In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placebo (n = 27) for 28 days. Serum ASD, dihydrotestosterone (DHT), free and total testosterone, estradiol, prostate-specific antigen (PSA), and lipid concentrations were measured at week 0 and each week throughout the supplementation period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free testosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1-4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r2 = 0.024), free testosterone (r2 = 0.00), or estradiol (r2 = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r2 = 0.244; P < 0.05). Serum concentrations of high-density lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD, three times per day, does not increase serum total testosterone or PSA concentrations but does elicit increases in ASD, free testosterone, estradiol, and DHT and decreases serum high-density lipoprotein cholesterol concentrations.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.85.11.4074</identifier><identifier>PMID: 11095435</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Administration, Oral ; Adult ; Affect ; Age Factors ; Androstenedione - administration & dosage ; Androstenedione - blood ; Androstenedione - pharmacology ; Biological and medical sciences ; Cholesterol - blood ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Double-Blind Method ; Estradiol - blood ; Genital system. Reproduction ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Placebos ; Prostate-Specific Antigen - blood ; Testosterone - blood ; Time Factors</subject><ispartof>The journal of clinical endocrinology and metabolism, 2000-11, Vol.85 (11), p.4074-4080</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-ec3239f716dbc3706f5171b2868a882929e01177c87b180d27387efd776dc6e53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=791788$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11095435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BROWN, Gregory A</creatorcontrib><creatorcontrib>VUKOVICH, Matthew D</creatorcontrib><creatorcontrib>MARTINI, Emily R</creatorcontrib><creatorcontrib>KOHUT, Marian L</creatorcontrib><creatorcontrib>FRANKE, Warren D</creatorcontrib><creatorcontrib>JACKSON, David A</creatorcontrib><creatorcontrib>KING, Douglas S</creatorcontrib><title>Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placebo (n = 27) for 28 days. Serum ASD, dihydrotestosterone (DHT), free and total testosterone, estradiol, prostate-specific antigen (PSA), and lipid concentrations were measured at week 0 and each week throughout the supplementation period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free testosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1-4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r2 = 0.024), free testosterone (r2 = 0.00), or estradiol (r2 = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r2 = 0.244; P < 0.05). Serum concentrations of high-density lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD, three times per day, does not increase serum total testosterone or PSA concentrations but does elicit increases in ASD, free testosterone, estradiol, and DHT and decreases serum high-density lipoprotein cholesterol concentrations.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Affect</subject><subject>Age Factors</subject><subject>Androstenedione - administration & dosage</subject><subject>Androstenedione - blood</subject><subject>Androstenedione - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Double-Blind Method</subject><subject>Estradiol - blood</subject><subject>Genital system. Reproduction</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Placebos</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Testosterone - blood</subject><subject>Time Factors</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0DtLBDEUBeAgiq6P0lYGBLusuclkbqYU8QWCjYJdyCZ3cNbZZE1mC_-9s7hodZqPA-cwdg5iDhLE9dLPjZ4DzGuB9R6bQVtrjtDiPpsJIYG3KN-P2HEpSyGgrrU6ZEcAotW10jP2chdD8rmPVGUq6xQLlWpMlf_IKfa-cjHkVEaKFPo0oT6O7nMblRJ8C3XDv8llnoZQrSiesoPODYXOdnnC3u7vXm8f-fPLw9PtzTP3CnDk5JVUbYfQhIVXKJpOA8JCmsY4Y2QrWxIAiN7gAowIEpVB6gJiE3xDWp2wq9_edU5fGyqjXfXF0zC4SGlTLAo0GmUzQf4L_bSjZOrsOvcrl78tCLt90C69NdoC2O2Dk7_YFW8WKwr_enfZBC53wBXvhi676Pvy57AFNEb9AKrxdqY</recordid><startdate>20001101</startdate><enddate>20001101</enddate><creator>BROWN, Gregory A</creator><creator>VUKOVICH, Matthew D</creator><creator>MARTINI, Emily R</creator><creator>KOHUT, Marian L</creator><creator>FRANKE, Warren D</creator><creator>JACKSON, David A</creator><creator>KING, Douglas S</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001101</creationdate><title>Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men</title><author>BROWN, Gregory A ; VUKOVICH, Matthew D ; MARTINI, Emily R ; KOHUT, Marian L ; FRANKE, Warren D ; JACKSON, David A ; KING, Douglas S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-ec3239f716dbc3706f5171b2868a882929e01177c87b180d27387efd776dc6e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Affect</topic><topic>Age Factors</topic><topic>Androstenedione - administration & dosage</topic><topic>Androstenedione - blood</topic><topic>Androstenedione - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Double-Blind Method</topic><topic>Estradiol - blood</topic><topic>Genital system. Reproduction</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Placebos</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Testosterone - blood</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROWN, Gregory A</creatorcontrib><creatorcontrib>VUKOVICH, Matthew D</creatorcontrib><creatorcontrib>MARTINI, Emily R</creatorcontrib><creatorcontrib>KOHUT, Marian L</creatorcontrib><creatorcontrib>FRANKE, Warren D</creatorcontrib><creatorcontrib>JACKSON, David A</creatorcontrib><creatorcontrib>KING, Douglas S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROWN, Gregory A</au><au>VUKOVICH, Matthew D</au><au>MARTINI, Emily R</au><au>KOHUT, Marian L</au><au>FRANKE, Warren D</au><au>JACKSON, David A</au><au>KING, Douglas S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2000-11-01</date><risdate>2000</risdate><volume>85</volume><issue>11</issue><spage>4074</spage><epage>4080</epage><pages>4074-4080</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>In young men, chronic ingestion of 100 mg androstenedione (ASD), three times per day, does not increase serum total testosterone but does increase serum estrogen and ASD concentrations. We investigated the effects of ASD ingestion in healthy 30- to 56-yr-old men. In a double-blind, randomly assigned manner, subjects consumed 100 mg ASD three times daily (n = 28), or placebo (n = 27) for 28 days. Serum ASD, dihydrotestosterone (DHT), free and total testosterone, estradiol, prostate-specific antigen (PSA), and lipid concentrations were measured at week 0 and each week throughout the supplementation period. Serum total testosterone and PSA concentrations did not change with supplementation. Elevated serum concentrations of ASD (300%), free testosterone (45%), DHT (83%), and estradiol (68%) were observed during weeks 1-4 in ASD (P < 0.05). There was no relationship between age and changes in serum ASD (r2 = 0.024), free testosterone (r2 = 0.00), or estradiol (r2 = 0.029) concentrations with ASD, whereas the serum DHT response to ASD ingestion was related to age (r2 = 0.244; P < 0.05). Serum concentrations of high-density lipoprotein cholesterol were decreased by 10% during the supplementation period (P < 0.05). These results suggest that the ingestion of 100 mg ASD, three times per day, does not increase serum total testosterone or PSA concentrations but does elicit increases in ASD, free testosterone, estradiol, and DHT and decreases serum high-density lipoprotein cholesterol concentrations.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>11095435</pmid><doi>10.1210/jc.85.11.4074</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2000-11, Vol.85 (11), p.4074-4080 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_70785726 |
source | MEDLINE; Oxford University Press Journals; EZB Electronic Journals Library |
subjects | Administration, Oral Adult Affect Age Factors Androstenedione - administration & dosage Androstenedione - blood Androstenedione - pharmacology Biological and medical sciences Cholesterol - blood Cholesterol, HDL - blood Cholesterol, LDL - blood Double-Blind Method Estradiol - blood Genital system. Reproduction Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Placebos Prostate-Specific Antigen - blood Testosterone - blood Time Factors |
title | Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T20%3A54%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endocrine%20responses%20to%20chronic%20androstenedione%20intake%20in%2030-%20to%2056-year-old%20men&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=BROWN,%20Gregory%20A&rft.date=2000-11-01&rft.volume=85&rft.issue=11&rft.spage=4074&rft.epage=4080&rft.pages=4074-4080&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.85.11.4074&rft_dat=%3Cproquest_cross%3E70785726%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70785726&rft_id=info:pmid/11095435&rfr_iscdi=true |